Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BA | Common Stock | Award | $0 | +12.9K | +26.93% | $0.00 | 60.7K | Feb 16, 2022 | Direct | F1 |
holding | BA | Common Stock | 990 | Feb 16, 2022 | 401(k) plan | F2 | |||||
holding | BA | Common Stock | 4.32K | Feb 16, 2022 | Career Shares |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BA | Stock Option (Right to Buy) | Award | $0 | +33.7K | $0.00 | 33.7K | Feb 16, 2022 | Common Stock | 33.7K | $260.98 | Direct | F3, F4 |
Id | Content |
---|---|
F1 | Represents restricted stock units that will vest and settle in shares of the Company's common stock on a one-for-one basis on February 17, 2025. |
F2 | Reflects periodic contributions to the issuer's common stock fund in the issuer's 401(k) plan. Ownership in the issuer's 401(k) plan is represented by units in the issuer's common stock fund in the plan rather than shares of common stock. |
F3 | The exercise price is equal to 120% of the average of the high and the low trading prices on the date of the grant (the "Grant Date FMV"). The exercise price will be reduced to 110% of the Grant Date FMV if the issuer's total shareholder return ("TSR") over the three-year vesting period exceeds the median TSR for the peer group of companies listed in the award agreement. |
F4 | The option becomes vested and exercisable in full on February 16, 2025, which is the third anniversary of the date of grant. |